Product image of Latanoprost Stada (Latanoprost) supplied by GNH India

Latanoprost Stada

Active Ingredient:
Latanoprost
Origin:
EU

Latanoprost Stada (Latanoprost)

Latanoprost, the active ingredient in Latanoprost Stada, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure by increasing uveoscleral outflow and is indicated for the management of primary open‑angle glaucoma and ocular hypertension in adult patients.

GNH India supplies Latanoprost Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for eye‑care formulations across global markets, including emerging markets and established healthcare systems.

Manufacturer / TM Owner

Stadapharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Latanoprost is a prostaglandin analog used to reduce intra‑ocular pressure in glaucoma‑related conditions.

  • Primary open-angle glaucoma: reduces intra‑ocular pressure to slow disease progression.
  • Ocular hypertension: lowers eye pressure to prevent development of glaucoma.

How It Works

  • Latanoprost acts as an agonist at the prostaglandin F‑type (FP) receptors in the ciliary body. Activation of FP receptors remodels the extracellular matrix, enhancing uveoscleral outflow of aqueous humor. The increased outflow lowers intra‑ocular pressure, providing therapeutic benefit in glaucoma and ocular hypertension. The drug’s selective receptor binding minimizes systemic exposure while delivering a sustained pressure‑lowering effect.

Side Effects

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: transient hyperemia of the conjunctiva.
  • Increased eyelash growth: longer, thicker lashes may appear.
  • Iris pigmentation: gradual darkening of the iris color.
  • Eye irritation: burning or stinging sensation after instillation.
  • Blurred vision: temporary visual disturbance.
  • Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects

  • Severe allergic reaction: swelling, itching, or rash requiring medical attention.
  • Uveitis: inflammation of the uveal tract that may impair vision.
  • Corneal edema: swelling of the cornea leading to visual blur.
  • Paradoxical intra‑ocular pressure increase: unexpected rise in pressure.
  • Macular edema: fluid accumulation in the macula affecting central vision.

Precautions & Warnings

When prescribing Latanoprost, clinicians should observe the following precautions to ensure safe use.

  • Monitor intra‑ocular pressure: measure IOP regularly to assess therapeutic response.
  • Assess for ocular infection: avoid use in eyes with active bacterial or viral infection.
  • Discontinue contact lens use: patients should remove lenses while using the drops.
  • Pregnancy and lactation: prescribe only if potential benefit justifies potential risk.
  • Systemic prostaglandin sensitivity: exercise caution in patients with asthma or allergic disorders.
  • Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ophthalmic or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid)

  • Concomitant prostaglandin analogs: may increase risk of ocular irritation and pigment changes.
  • Non‑steroidal anti‑inflammatory eye drops: can reduce Latanoprost’s IOP‑lowering effect.
  • Systemic carbonic anhydrase inhibitors: additive pressure‑lowering may cause excessive IOP reduction.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: combined use may produce additive IOP reduction; monitor pressure.
  • Corticosteroid eye drops: may counteract the pressure‑lowering effect of Latanoprost.
  • Anticholinergic agents: potential reduction in aqueous outflow; observe IOP trends.

Frequently Asked Questions

Latanoprost Stada is an ophthalmic solution containing the prostaglandin analog latanoprost. It is prescribed to lower intra‑ocular pressure in adults with primary open‑angle glaucoma or ocular hypertension, helping to slow disease progression and reduce the risk of vision loss.

Latanoprost binds to prostaglandin F‑type (FP) receptors in the eye’s ciliary body. This activation remodels the extracellular matrix, enhancing the uveoscleral pathway for aqueous humor outflow. The increased drainage reduces intra‑ocular pressure, providing therapeutic benefit in glaucoma and ocular hypertension.

The dosing regimen for Latanoprost Stada is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and timing should follow the healthcare professional’s instructions.

The safety of Latanoprost Stada in pregnancy or while nursing has not been definitively established. It should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To request Latanoprost Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and a strong IOP‑lowering effect. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often achieve greater pressure reduction with a favorable systemic safety profile, though individual response may vary.

Latanoprost Stada should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from light and moisture, and avoid freezing. Do not refrigerate unless specifically instructed by the manufacturer.

Latanoprost Stada is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place one drop into the conjunctival sac of the prescribed eye(s). Close the eye gently and avoid blinking excessively for a few seconds.

Although uncommon, serious adverse events can include severe allergic reactions, uveitis, corneal edema, paradoxical increase in intra‑ocular pressure, and macular edema. Patients should seek immediate medical attention if they experience sudden pain, vision changes, swelling, or signs of an allergic response.

Latanoprost Stada is contraindicated in individuals with known hypersensitivity to latanoprost or any component of the formulation, and it should be avoided in eyes with active inflammation or infection. Caution is also advised for patients with a history of asthma, severe ocular surface disease, or those who are pregnant or breastfeeding without clear benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT